Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells. | Biomed Pharmacother | 2021 | 34328096 | PubTator, text mining | PubMed |
| Breast cancer resistance mechanisms: challenges to immunotherapy. | Breast Cancer Res Treat | 2021 | 34322780 | PubTator, text mining | PubMed |
| Immune implication of FAM83D gene in hepatocellular carcinoma. | Bioengineered | 2021 | 34308751 | PubTator, text mining | PubMed |
| Phenotypic and Functional Analyses of B7S1 in Ovarian Cancer. | Front Mol Biosci | 2021 | 34307455 | PubTator, text mining | PubMed |
| The Expression of PD-L1 and B7-H4 in Thymic Epithelial Tumor and Its Relationship With Tumor Immune-Infiltrating Cells. | Front Oncol | 2021 | 34307135 | PubTator, text mining | PubMed |
| A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma. | Front Mol Biosci | 2021 | 34291083 | PubTator, text mining | PubMed |
| Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis. | Reprod Biol Endocrinol | 2021 | 34289871 | PubTator, text mining | PubMed |
| Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity. | Front Cell Dev Biol | 2021 | 34277633 | PubTator, text mining | PubMed |
| Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma. | Front Cell Dev Biol | 2021 | 34277600 | PubTator, text mining | PubMed |
| Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors. | Front Oncol | 2021 | 34277411 | PubTator, text mining | PubMed |
| Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry. | Front Immunol | 2021 | 34276685 | PubTator, text mining | PubMed |
| The prognostic landscape of tumor-infiltrating immune cells in lung squamous cell carcinoma. | Ann Transl Med | 2021 | 34268412 | PubTator, text mining | PubMed |
| Epigenetic Changes in Neonates Born to Mothers With Gestational Diabetes Mellitus May Be Associated With Neonatal Hypoglycaemia. | Front Endocrinol (Lausanne) | 2021 | 34267729 | PubTator, text mining | PubMed |
| Targeting the spectrum of immune checkpoints in prostate cancer. | Expert Rev Clin Pharmacol | 2021 | 34263692 | PubTator, text mining | PubMed |
| Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients. | J Oncol | 2021 | 34257652 | PubTator, text mining | PubMed |
| Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer. | Bioengineered | 2021 | 34252356 | PubTator, text mining | PubMed |
| Unraveling the Spatiotemporal Human Pluripotency in Embryonic Development. | Front Cell Dev Biol | 2021 | 34249929 | PubTator, text mining | PubMed |
| Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma. | Aging (Albany NY) | 2021 | 34247148 | PubTator, text mining | PubMed |
| KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. | Sci Immunol | 2021 | 34244312 | PubTator, text mining | PubMed |
| Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade. | J Immunother Cancer | 2021 | 34230109 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=58